REEP6 activators refers to a class of chemical compounds and agents that have the capacity to influence or enhance the activation of REEP6, a protein intricately associated with the structure and function of the endoplasmic reticulum (ER). These activators operate at a molecular level to modulate the behavior of REEP6, either directly or indirectly, by affecting cellular processes and signaling pathways. The role of REEP6 in maintaining ER morphology and homeostasis makes it a pivotal component in various fundamental cellular functions, including protein synthesis, lipid metabolism, and calcium storage. Consequently, the discovery and characterization of REEP6 activators hold significant implications for our understanding of ER dynamics and cellular physiology.
REEP6 activators encompass a diverse array of chemicals and compounds, each with distinct mechanisms of action. These may include molecules that target ER stress responses, calcium signaling, or metabolic pathways, among others. For example, some activators function as chemical chaperones, aiding in the proper folding of proteins within the ER. Others may impact calcium flux within the ER lumen, which is crucial for processes like protein secretion and cell signaling. Additionally, some activators might affect autophagy, a cellular process tightly linked to ER maintenance. In essence, REEP6 activators offer researchers a toolkit for exploring the intricate world of ER biology, shedding light on the molecular underpinnings of its structure and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Tauroursodeoxycholic Acid, Sodium Salt | 14605-22-2 | sc-281165 | 1 g | $644.00 | 5 | |
As a chemical chaperone, it has the potential to directly or indirectly activate REEP6 by modulating ER stress and protein folding pathways. | ||||||
4-Phenylbutyric acid | 1821-12-1 | sc-232961 sc-232961A sc-232961B | 25 g 100 g 500 g | $52.00 $133.00 $410.00 | 10 | |
This compound can indirectly increase the activation of REEP6 by modulating ER stress pathways, potentially enhancing ER homeostasis. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
By regulating calcium signaling, Thapsigargin can indirectly activate REEP6, affecting calcium storage and release in the ER. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AICAR, as an AMPK activator, may indirectly activate REEP6 by increasing cellular energy homeostasis and potentially affecting the ER. | ||||||
Guanabenz acetate | 23256-50-0 | sc-203590 sc-203590A sc-203590B sc-203590C sc-203590D | 100 mg 500 mg 1 g 10 g 25 g | $100.00 $459.00 $816.00 $4080.00 $7140.00 | 2 | |
Guanabenz indirectly activates REEP6 by modulating Unfolded Protein Response (UPR) pathways, increasing ER stress and protein folding. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
As an autophagy inducer, Rapamycin indirectly activates processes closely linked to REEP6, enhancing REEP6 activation and ER homeostasis. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $254.00 | 41 | |
Rotenone indirectly activates REEP6 by modulating mitochondrial function, which may enhance REEP6 activation by affecting ER-mitochondria crosstalk. | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $51.00 | 7 | |
Lipase Inhibitor, THL can indirectly activate REEP6 by increasing lipid metabolism pathways, which are closely tied to ER function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
As a proteasome inhibitor, Bortezomib can indirectly activate REEP6 by disrupting protein degradation pathways, potentially increasing the ER. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A indirectly activates REEP6 by affecting gene expression, potentially increasing ER-related processes. |